If you are a member of the media and have questions about Bayer in Canada, please contact Marija Mandic, Director of Communications, at, or 905-282-5376.


March 9, 2015
Bayer introduces Xofigo, a novel treatment for prostate cancer, now publicly funded for patients in Ontario more
December 1, 2014
Bayer Receives Health Canada Approval for Eylea® for Two Additional Indications more
November 13, 2014
Bayer CropScience Unveils State-of-the-Art Packaging Facility more
November 4, 2014
Eight is Great! Bayer named one of Canada’s Top 100 Employers for the eighth consecutive year more
October 22, 2014
ASPIRIN® 81mg for Emergency Use during Heart Attacks: Approved in Canada more
October 20, 2014
Mike Weir Takes a Swing for Arthritis: Golf icon and ALEVE® spokesperson encourages Canadians to break free from their pain more
October 1, 2014
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion more
July 15, 2014
Bayer’s New CONTOUR® NEXT LINK Blood Glucose Meter Now Available in Canada more
July 7, 2014
Nexavar® (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer more
June 17, 2014
Bayer introduces JAYDESS®, a simple and safe alternative to the ‘Pill’ more
May 12, 2014
Bayer’s Grants4Apps Initiative Looking for Canada’s Most Innovative Digital Healthcare Startups more
May 2, 2014
Young and Employable: Bayer Among the Best Places to Work more
April 28, 2014
Positive Results from Phase III DECISION Study of Sorafenib in RAI-Refractory Differentiated Thyroid Cancer Published in... more
April 24, 2014
Quebecers suffering from wet Age-Related Macular Degeneration first with government coverage more
April 24, 2014
Québec First Province to List Adempas® for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) more
April 22, 2014
Two Green Thumbs Up for Bayer! Bayer named one of Canada’s Greenest Employers for the sixth consecutive year more
April 17, 2014
When Living With Hemophilia, It’s All About Attitude more
March 10, 2014
Adempas® now approved for second rare heart and lung disease, offering a new treatment option to improve patient care more
February 26, 2014
No Need to Fret, Ferret Friends! Advantage Multi® 9 is the First and Only Approved Therapy to Prevent Heartworm Disease... more
February 5, 2014
New Study: 4 in 10 Canadians Admit They Or A Partner Have Had A ‘Pregnancy Scare’ more

You are now leaving